findmyKOL
Clinical trialNCT03393247UnknownInterventional

The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD

SponsorSixth Affiliated Hospital, Sun Yat-sen UniversityEnrollment160Crohn Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the Sixth Affiliated Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jun 2017
Primary completion
1 Jul 2018
Completion
1 Jul 2019
Last update posted
8 Jan 2018
Registered enrollment
160
Registry id
NCT03393247

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.